Task: Answer the multiple-choice question.
Question: Which compound exhibits a -5.178% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) COc1ccc(CN2CCC(n3nccc3NC(=O)C3CCCC3)CC2)c(OC)c1
b.) c1ccc(C2=Nn3c(nnc3-c3cccnc3)SC2)cc1
c.) Clc1ccc2nc(CSc3nncn3-c3ccccc3)cn2c1
d.) Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)c1ccccc1
Answer: c. Clc1ccc2nc(CSc3nncn3-c3ccccc3)cn2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc2nc(CSc3nncn3-c3ccccc3)cn2c1
Clc1ccc2nc(CSc3nncn3-c3ccccc3)cn2c1
6-chloro-2-[(4-phenyl-1,2,4-triazol-3-yl)sulfanylmethyl]imidazo[1,2-a]pyridine